Exercise Training in Patients with Pulmonary Hypertension: A Systematic Review and Meta-analysis.

[Exercise Training in Patients with Pulmonary Hypertension: A Systematic Review and Meta-analysis]. Pneumologie. 2019 Nov;73(11):677-685 Authors: Glöckl R, Schneeberger T, Boeselt T, Kenn K, Koczulla AR, Held M, Oberhoffer R, Halle M Abstract BACKGROUND:  Pulmonary hypertension (PH) is defined as an elevation of mean pulmonary-arterial pressure by> 20 mmHg at rest, which may lead to right heart failure. Physical exercise has not been regularly recommended for PH patients for fear of symptom deterioration or occurrence of exercise-induced adverse events. METHODS:  Three electronic databases were searched for randomized, controlled trials investigating exercise training in PH patients using the following keywords: "pulmonary hypertension" OR "pulmonary arterial hypertension" AND "exercise" OR "pulmonary rehabilitation" AND "randomized". RESULTS:  Five studies involving 187 PH patients were included in this systematic review. Exercise programs lasted for 3 - 12 weeks (e. g. endurance training for 10 - 45 minutes; 60 - 80 % of the peak heart rate). PH patients significantly improved exercise capacity compared to controls in 6-minute walk distance (+ 45 m; 95 % CI: 26 m - 64 m) or peak oxygen consumption (+ 2.3 ml/kg/min; 95 % CI: 1.8 - 2.9 ml/kg/min), both p 
Source: Pneumologie - Category: Respiratory Medicine Tags: Pneumologie Source Type: research

Related Links:

We present the case of a 74-year-old woman with a history of hypertensive heart disease with preserved systolic function, atrial fibrillation and dyslipidemia. She had a DDDR pacemaker implanted in 2005 due to symptomatic complete atrioventricular block.The patient reported progressive fatigue, weakness, ascites with abdominal discomfort, and lower limb edema, accompanied by non-specific hepatic cholestasis on biochemical testing. Abdominal ultrasound revealed homogeneous hepatomegaly and dilatation of the inferior vena cava and upper hepatic veins, suggestive of congestive hepatopathy.Echocardiography revealed tricuspid r...
Source: Revista Portuguesa de Cardiologia - Category: Cardiology Source Type: research
Background: Pulmonary hypertension (PH) and right heart failure are common complications of COPD. Its presence is associated with shorter survival and worse clinical outcome. Vasodilators are supposed to reduce PH and improve cardiac function.Aim: To study the hemodynamic effects and wsafety of the use of Angiotensin II receptor blockers (ARBs) inhibitor Valsartan in secondary PH in patients with COPD.Material and methods: The study included 40 patients (mean age 45.0±2.0 years) with stable COPD and secondary PH, divided into 2 groups, comparable by age, sex, duration and stage of the disease. Patients in group 1 (n...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Airway pharmacology and treatment Source Type: research
Conclusion: The prevalence of PH with a RVSP>35 mmHg or CHF with an LVEF 1 is not a useful cardiac screening tool for PH. Perpendicular PA measurements may be helpful in preselecting patients for echocardiography, but needs to be evaluated in larger numbers of patients with PH.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Thoracic surgery Source Type: research
Introduction: COPD has several comorbidities, including right heart failure (RHF), decreasing the functional capacity of patients due to their common symptomatology. This condition can be related to psychological comorbidities such as anger, anxiety and depression.Aim: To investigate the levels of anger, anxiety, depression and quality of life in patients with COPD+RHF, depending on their functional capacity.Method: A descriptive cross-sectional study was recorded including 75 COPD+RHF patients, who were classified according to NYHA in I (N = 10), II (N = 33), III (N =29) and IV (N = 3). We used Hospital Anxiety and Depres...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
Background: Right ventricular failure (RVF) is the major prognostic factor in pulmonary arterial hypertension (PAH). Recent Omics analyses have demonstrated the deregulation of several long non-coding RNAs (LncRNAs) in left heart failure, but their role in RVF remains unknown. The LncRNA H19 and its encoded miR-675 have been implicated in both cardiac hypertrophy and fibrosis (2 features of RVF) but never been studied in RVF.Methods and Results: By qRT-PCR, we showed in human RV biopsies obtained from control donors, compensated RV hypertrophy patients (CRVH, Cardiac index> 2.2) and decompensated RV hypertrophy patients...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
Conclusion: Despite normalization of MAO-A activity in PTB rats, no functional improvements or changes in cardiac size were observed. Histological analyses will further elucidate these findings.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
Conclusion: PAH patients presented with complex and fragile comorbidity profiles consistent with previously published data. Follow-up was commonly marked by modifications to medication regimens and inpatient admissions.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
Conclusions: there is no benefit on survival with the long term use of digoxin, except for rehospitalization and functional class.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
Introduction: Pulmonary hypertension (PH) is a rare complication of hereditary hemorrhagic telangiectasia (HHT). This is usually a post-capillary PH (group 2), due to high cardiac output and leading to left-heart failure. More rarely, it can result from pulmonary vascular remodeling (pre-capillary PH). We investigated prevalence, hemodynamic profiles and associated clinical conditions of pre-capillary PH associated with HHT.Methods: We conducted a retrospective monocentric study in the French national reference center (Lyon, France) among patients with confirmed HHT who underwent right heart catheterization (RHC). Patients...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
Backgrounds: Chronic thromboembolic disease (CTED) is characterized by similar symptoms and perfusion defect as chronic thromboembolic pulmonary hypertension (CTEPH), but without pulmonary hypertension at rest. Recently, successful pulmonary endarterectomy (PEA) and balloon pulmonary angioplasty (BPA) for symptomatic patients with CTED has been reported. However, it remains unclear whether CTED evolves to CTEPH. The aim of this study is to clarify the natural history of CTED.Methods: Consecutive patients diagnosed as CTED between 1986 and 2017 were retrospective enrolled. CTED was defined as follows: a mean pulmonary arterial pressure at rest
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research
More News: Cardiology | Databases & Libraries | Heart | Heart Failure | Hypertension | Men | Pulmonary Hypertension | Rehabilitation | Respiratory Medicine | Sports Medicine | Study | Training | Universities & Medical Training